T1	Participants 466 525	hospitalized patients with ocular hypertension or glaucoma.
T2	Participants 526 547	Patients in group 1 (
T3	Participants 621 640	Patients in group 2
T4	Participants 734 740	groups
T5	Participants 909 917	patients
T6	Participants 1430 1466	control eyes in group 1 and group 2,
T7	Participants 1250 1271	mean nocturnal IOPs (
